Deep infection following total joint arthroplasty is a devastating complication for the patient and a costly one for patients, surgeons, hospitals, and insurance companies. With the increased usage of total joint implant, the number of biofilm-associated infections has emerged as a significant clinical problem because biofilms are often resistant to traditional antimicrobial therapy and difficult to eradicate. My expertise and research focuses on novel diagnostic and treatment modalities in biofilm-related periprosthetic joint infections and revision surgery.\n\n
